August 18, 2021
Tag:
Under the background of the implementation of new Pharmacopoeia, Consistency Evaluation of Generic Drugs, Marketing Authorization Holder, CGMP, Approval System for Pharmaceutical Packaging Materials and Pharmaceutical Excipients, pharmaceutical enterprises have started to independently improve product quality and take responsibility for their self-produced products, which greatly enhance their initiatives. At the same time, the policies also accelerate the further development of the overall domestic pharmaceutical industry.
Nanjing Chemical Material Corporation(NCMC) actively participated in 2021 API China(Guangzhou) with products including inorganic iodides, special esters, amines, nitriles and other pharmaceutical raw materials and intermediates. Under the premise of the unfavorable economic environment and the impact of the epidemic, all the players are thinking about the plans of the industry prospect and making efforts to better serve the market, NCMC fully exchanged views on these aspects with attendees.
Due to the affection of epidemic controlling as well as rainstorm in Guangzhou, the three-day exhibition was shortened to one day finally. Eventhough the exhibition time was limited, NCMC participated as scheduled and obtained a very good chance to communicate and serve all the suppliers and customers.
NCMC look forward to meeting all of the friends and partners in API China(Wuhan) held in 2021 H2.
Previous:the year 2019
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: